Free Trial
OTCMKTS:DTCFF

Defence Therapeutics (DTCFF) Stock Price, News & Analysis

Defence Therapeutics logo
$0.76 0.00 (0.00%)
As of 05/28/2025

About Defence Therapeutics Stock (OTCMKTS:DTCFF)

Key Stats

Today's Range
$0.76
$0.76
50-Day Range
$0.62
$1.00
52-Week Range
$0.27
$1.16
Volume
N/A
Average Volume
17,215 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Receive DTCFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Defence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DTCFF Stock News Headlines

Defence Therapeutics Inc.
Defence Therapeutics Inc (DTC.DU)
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Defence Therapeutics Strengthens Leadership with Key Appointments
Defence Therapeutics to License Accum Technology
Defence Therapeutics Welcomes Radiopharmaceutical Expert
See More Headlines

DTCFF Stock Analysis - Frequently Asked Questions

Defence Therapeutics' stock was trading at $0.3901 at the beginning of 2025. Since then, DTCFF stock has increased by 94.2% and is now trading at $0.7578.
View the best growth stocks for 2025 here
.

Shares of DTCFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DTCFF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:DTCFF) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners